Competing interests
Johnson & Johnson.
EVENTS
CL received a speaking fee from Boston Scientific.JBG is a consultant for Boston Scientific and has received a research grant from Boston Scientific.DB received speaking fees from Takeda, MSD, Ferring, and Pfizer.DM Payment or honoraria for lectures, presentations, speaker bureaus, or educational events from Johnson & Johnson. Support for attending meetings and/or travel from Takeda.FPR is a consultant for Boston Scientific.FGH is a consultant for Boston Scientific and Ambu.AV received a speaking fee from Janssen and Tillots Pharma.ME has received support for conference attendance and research support from Abbvie, Biogen, Faes Farma, Ferring, Jannsen, MSD, Pfizer, Takeda, and Tillotts.MM has served as a speaker and has received research and an educational grant and advisory fees from AbbVie, Takeda, Pfizer, Janssen, Galapagos, and Ferring.MMBW declares educational activities, research projects, scientific meetings, and advisory boards sponsored by MSD, Ferring, Abbvie, Janssen, Biogen, and Takeda.VP is a consultant for Boston Scientific.JG has served as a speaker, consultant, and advisory member for or has received research funding from Roche, MSD, Abbvie, Kern Pharma, Takeda, Janssen, Pfizer, Ferring, Chiesi, Galapagos, Sandoz, Celltrion, and GE Healthcare.The other authors declare that they have no competing interests.